Eighteen compounds of novel quinoxaline derivatives were designed and synthesized. Molecular docking and pharmacophore studies were carried out. In vivo anti-hyperglycemic activity, in vitro PPARγ binding affinity and insulin-secreting ability were carried out. Some of the synthesized compounds showed promising anti-hyperglycemic activity.